6-K ·Filed Jul 1, 2026
Notable filing: 6-K
Actionable Insight • Neutral
This filing is purely administrative with no trading implications. Monitor for any larger equity issuance or share buyback announcements that would materially affect share count.
Final — all horizons settled through T+60d ⚠ clustered
AZN ▼ -10.50% at T+60d
NEUTRAL call ✗ call lost -10.50% · α vs SPY -13.45% · entry $183.86 → $164.56
T+1d
+6.14%
call +6.14% · α +6.27%
$195.15
settled 3mo ago
T+5d
+5.04%
call +5.04% · α +4.78%
$193.12
settled 3mo ago
T+20d
-5.74%
call -5.74% · α -3.56%
$173.30
settled 2mo ago
T+60d
-10.50%
call -10.50% · α -13.45%
$164.56
settled 7d ago
Price Chart
Loading chart...
Executive Summary
AstraZeneca filed a routine 6-K reporting the admission of 14,784 ordinary shares issued under employee share schemes during June 2026. The new shares represent ~0.001% dilution to the 1.55B shares outstanding — immaterial and administrative in nature.
Key Facts
- 14,784 ordinary shares of $0.25 each were admitted to trading on the London Stock Exchange Main Market
- Shares were issued under employee share schemes between June 1 and June 30, 2026
- Total shares outstanding post-admission: 1,551,024,534
- New shares are fully fungible with existing ordinary shares (ISIN: GB0009895292)
- Admission was under a block admission dated January 29, 2021
Financial Impact
Negligible dilution of ~0.001% of outstanding shares; no material financial impact
dilution
Market Snapshot
Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
83% bullish (35 analysts)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001654954-26-006430 |
| Document: 0001654954-26-006430-index-headers.html | 0001654954-26-006430 |
| Document: 0001654954-26-006430-index.html | 0001654954-26-006430 |
| Document: 0001654954-26-006430.txt | 0001654954-26-006430 |
54 reports for AZN
67% Hit rate best @ T+60▲ +13.65%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | 6-K | $161.85 $168.37 | ▲ +4.03% | ▲ +1.90% | $156.97 (−3.02%) |
Sep 14, 2026 18d ago | 6-K | $163.78 $168.10 | ▼ −2.64% | ▼ −2.53% | $156.97 (+4.16%) |
Sep 8, 2026 24d ago | 6-K | $160.04 $161.85 | ▲ +1.13% | ▲ +2.25% | $156.97 (−1.92%) |
Sep 1, 2026 4w ago | 6-K | $162.22 $156.94 | ▼ −3.25% | ▼ −3.33% | $156.97 (−3.23%) |
Sep 1, 2026 4w ago | 6-K | $162.22 $156.94 | ▼ −3.25% | ▼ −3.33% | $156.97 (−3.23%) |
Sep 1, 2026 4w ago | 6-K | $162.47 $156.94 | ▼ −3.40% | ▼ −3.49% | $156.97 (−3.39%) |
Sep 1, 2026 4w ago | 6-K | $162.22 $156.94 | ▼ −3.25% | ▼ −3.33% | $156.97 (−3.23%) |
Sep 1, 2026 4w ago | 6-K | $162.22 $156.94 | ▼ −3.25% | ▼ −3.33% | $156.97 (−3.23%) |
Sep 1, 2026 4w ago | 6-K | $162.47 $156.94 | ▼ −3.40% | ▼ −3.49% | $156.97 (−3.39%) |
Aug 31, 2026 4w ago | Court Ruling | $162.13 $159.95 | ▲ +1.34% | ▲ +1.20% | $156.97 (+3.18%) |
Showing 10 of 54
US Market Status
Market Open — Closes in 52m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access